![]() |
|
|
INTRODUCTION
Tobacco kills one in two smokers who
use cigarettes as intended by the manufacturer. Worldwide this represents almost 4,000,000 deaths per year, or
around one every eight seconds.[1] In Australia, smoking kills 18,000 per year
and costs the nation around $12 billion annually. There are approximately 3.5 million smokers in Australia half of
whom will die prematurely from smoking-related disease. This is about 1.8 million people or almost
10% of the Australian population.
Comparable figures can no doubt be obtained for the various countries
throughout the world. All this raises the question: “How
did this happen and what can be done about it?” In this paper the historical background to the smoking pandemic
of the 20th century is set out and various responses to it including
the response of the World Health Organisation (WHO) to establish an
International Framework Convention On Tobacco Control (FCTC) which is examined
particularly in the context of implications for the Asia/Pacific region. BACKGROUND
The
historical background to the smoking pandemic of the 20th century
has been well documented. Essentially,
whilst there have been warnings about the harmful effects of smoking dating
back to James I of England’s Counterblaste to tobacco in 1604, it was
only with the publication of five medical studies in 1950 that a real
scientific basis for linking smoking with death and disease was established.[2],[3],[4],[5],[6] The first of these, by Ernst Wynder, was
published in the Journal of the American Medical Association on 27 May
1950. Another by Richard Doll and
Austin Bradford Hill, Smoking and Carcinoma of the Lung. A Preliminary Report appeared in the British Medical Journal of 15 September
1950. In time, these studies became the
leading references on their respective sides of the Atlantic and, jointly, throughout
the world. Later
knighted for his work in the field, Sir Richard Doll went on the publish
numerous papers recording, with ever-increasing certainty, the link between
smoking and various diseases based on following the health of a cohort of British
doctors and establishing the correlation between smoking habits and disease
outcomes. Indeed, Doll’s most recent
contribution, Smoking, Smoking Cessation and Lung Cancer in the UK Since
1950: Combination of National Statistics with Two Case – Control Studies,
appeared in a special commemorative issue of the British Medical Journal on 5 August 2000, 50 years on from his
first publication on the topic.[7] Meanwhile,
Ernst Wynder went on to conduct further research and publish additional
findings, including one appearing in Cancer Research in 1953[8]
reporting the development of cancerous tumors on mice whose backs had been
experimentally painted with a concentrate of cigarette tar, which precipitated
a course of events, the repercussions of which are still reverberating around
the world today. It is remarkable that so much is
known with such precision about how the tobacco industry conspired to
perpetrate a fraud on the world community which has persisted for half a
century. On 15 December 1953, directly
as a result of the Wynder tar painting experiment, the chiefs of all the US
tobacco companies (excepting Liggett) met at the Plaza Hotel in New York City
to devise a response. It is now
notorious that the response was to hire a publicity relations firm, Hill &
Knowlton, representatives of whom in fact attended the 15 December meeting, to
embark on an elaborate subterfuge to conceal or distort the scientific evidence
linking smoking with death and disease commencing with the Frank Statement
advertising campaign which was initiated by way of full-page advertisements on
4 January 1954 appearing in 448 newspapers in 258 cities throughout the US
reaching an estimated 43,245,000 readers.[9]
The
advertisement entitled A Frank Statement to Cigarette Smokers, stated: Recent reports on
experiments with mice [conducted by Wynder, Graham, and Croninger, who found
that painting mice with tobacco tar caused cancer] have given wide publicity to
a theory that cigarette smoking is in some way linked with lung cancer in human
beings … Many people have asked us what we
are doing to meet the public’s concern aroused by the recent reports. Here is the answer: 1. We are
pledging aid and assistance to the research effort into all phases of tobacco
use and health … 2. For
this purpose we are establishing a joint industry group consisting initially of
the undersigned. This group will be
known as TOBACCO INDUSTRY RESEARCH COMMITTEE. 3. In
charge of the research activities of the Committee will be a scientist of
unimpeachable integrity and national repute.
In addition there will be an Advisory Board of scientists disinterested
in the cigarette industry … This statement is
being issued because we believe the people are entitled to know where we stand
on this matter and what we intend to do about it. The Frank
Statement also sets out the tobacco industry’s claimed concern for the
health of its smokers: ‘We accept an interest in people’s health as a basic
responsibility paramount to every other consideration in our business.’ Contrary
to this voluntary and public undertaking, through the Tobacco Industry Research
Centre (TIRC) and, later, the renamed Council for Tobacco Research (CTR), the
participating tobacco companies deliberately distorted scientific fact for
their own commercial gain. The activities
of TIRC and CTR in this regard are well documented. A small sample of documents, largely from Brown and Williamson,
formed the basis of an insightful analysis in a series of articles published in
the 19 July 1995 issue of the Journal of
the American Medical Association.
As summarised in a paper by University of California Professor of
Medicine, Stan Glantz and others, styled Looking Through a Keyhole at the
Tobacco Industry, these documents reveal a deliberate course of deception
over several decades in which public statements by the tobacco industry on such
topics as nicotine and addiction, smoking and disease, environmental tobacco
smoke, and even the role of TIRC/CTR, can be seen to be demonstrably false and
misleading by reference to internal research results and private statements.[10] These
documents, and what they reveal, are the subject of an even more detailed
analysis in the 529 page text The Cigarette Papers by Glantz and others
published by University of California Press in 1996. Many more documents were uncovered and used in various tobacco
litigation cases in the US, starting in the 1980s and especially in the 1990s,
as described in various books on the subject.[11],[12],[13],[14],[15]
Moreover,
two of the major world tobacco companies, being the two which primarily operate
in Australia, have effectively admitted that the public stance they have taken
over the decades is at odds with the overwhelming consensus in the world
scientific community.[16],[17] Indeed, the Philip Morris website cites a
catalogue of US Surgeon Generals’ Reports on smoking and health dating back to
1964 as references to support the admission that there is an overwhelming
consensus in the scientific community that smoking causes lung cancer and other
serious diseases. Further,
documents now available on the worldwide web as a result of tobacco litigation
in the US evidence the formation of a formal conspiracy between seven of the
world’s major tobacco companies, including BAT and Philip Morris, to promote a
“false” controversy over smoking and disease and to implement strategies of
“smoker reassurance” to allay smokers’ concerns over the link between smoking
and disease.[18] Suffice to say, the conduct of the
tobacco industry in the US has been comprehensively demonstrated to be fraudulent
and deceitful and, to the extent that it can be shown to have been engaged in
elsewhere, this applies in other places throughout the world including in the
South Pacific. RESPONSES TO TOBACCO
INDUSTRY CONDUCT From the first discovery of evidence
scientifically linking smoking with disease, the health and medical community
have responded by advocating ever-increasingly stringent measures directed at
tobacco control. The first significant
step in this direction was the preparation of the first US Surgeon General’s
report on tobacco released in 1964.[19] Since then numerous reports on the subject
have been prepared in various countries throughout the world including 29
reports on the subject by the US Surgeon General, the most recent being Reducing
Tobacco Use released in September 2000.[20] Publication of these reports has resulted in
increased international cooperation commencing with the 1st World Conference on
Tobacco OR Health in New York City in 1977, the 11th World
Conference being held in Chicago in August 2000. Along the way many countries have
introduced legislation directed at tobacco control but to a varying extent in
different countries. At the same time
many attempts have been made by way of litigation to make the tobacco industry
accountable for its actions. This has
been most successful in the United States although that success has prompted
other litigation worldwide.[21] In was of course, as stated above,
litigation in the United States which resulted in the public disclosure of
tobacco companies’ documents which have implicated the industry throughout the
world. Litigation currently on foot in
the United States, Australia and elsewhere may result in the tobacco industry
being made accountable for its conduct at least to some extent. However, for some countries a litigation
response may not be a realistic option and, in any case, there is an urgent
need for an equitable and effective worldwide response. It is in this context that it was
first proposed at the 10th World Conference on Smoking OR Health in
Beijing in 1997 that the WHO invoke its power to promote an International
Framework Convention on Tobacco Control.
Since then the World Health Assembly have approved WHO embarking on this
course with the result that a timetable for implementing an FCTC has been
devised and is currently being implemented.
Just last week WHO commenced Public Hearings in Geneva into the conduct
of the tobacco industry as a preliminary to further development of FCTC during
the course of this week. It is therefore
timely to consider the WHO’s proposed FCTC and its implications for the Pacific
Island Region. INTERNATIONAL FRAMEWORK CONVENTION ON TOBACCO CONTROL A Framework Convention is an
international legal instrument, which allows law making to proceed incrementally,
by establishing a general system of governance for an issue area, and then
developing more specific commitments and institutional arrangements in
protocols. A convention is another name for a treaty - an international legal
agreement concluded between States in written form and governed by
international law. The term protocol is generally used to refer to a subsidiary
international agreement that supplements or extends an earlier or concurrent
international agreement. In the context of framework conventions, protocols
build on the parent convention through the elaboration of additional or more
specific commitments and institutional arrangements The Framework Convention on Tobacco
Control (FCTC) with related protocols will offer an approach found in numerous
human rights and environmental treaties. The development of the FCTC will
represent the first time that the World Health Organization (WHO) has used its
constitutional mandate to facilitate the creation of an international
convention, making the FCTC the first multilateral convention focussing
specifically on a public health issue. History In May 1996, the World Health
Assembly adopted Resolution WHA 49.17 that called upon the Director General of
WHO to initiate the development of a Framework Convention on Tobacco Control. Between 1996-1999 preparatory
technical work was undertaken. On 24 May 1999, the World Health Assembly
unanimously adopted Resolution WHA 52.18 that maps the process for negotiation
of the FCTC. Formal negotiations on the FCTC
commence with the convening of the first meeting of the Intergovernmental
Negotiating Body in Geneva from 16-21 October 2000. Rationale Globally, the number of deaths from
tobacco is increasing. Tobacco is currently responsible for the deaths of over
3.5 million people each year or one death every 8 or 9 seconds. Unless current
trends are reversed, by the decade 2020-2030, tobacco will kill 10 million
people a year (World Health Organization, 1998). According to WHO: 'The enormity and the gravity of the
present and future worldwide tobacco epidemic mean that the adoption of an
international instrument for tobacco control has become urgent. Although 91
countries have enacted tobacco control legislation, many countries still have
weak or no legislation and their response to the dangers of tobacco use has
been limited. The aggressive marketing practices of the multinational tobacco
companies threaten the lives and health of the people in both developing and
industrialised countries.' (WHO FCTC technical briefing papers, 1999) 'Four factors form the basis for
present efforts towards a collective international response to tobacco-caused
death and disease:
(i) the scope of the damage makes tobacco a public health tragedy of the
first order;
(ii) the problem exists in every country;
(iii) key elements, smuggling for instance - transcend national
boundaries; and
(iv) the tobacco problem has proved incapable of being fully tamed by
countries acting in isolation.' (WHO FCTC technical briefing papers, 1999) Process for
development On 24 May 1999, the World Health
Assembly unanimously adopted Resolution WHA52.18, which maps the process for
negotiation of the FCTC, including the establishment of an FCTC Working Group
and an Intergovernmental Negotiating Body to draft and negotiate the proposed
FCTC and Protocols. The FCTC will be developed by WHO's 191 member states. The
content of the Convention and its related Protocols will depend on the member
states of WHO. The mission of the FCTC Working Group,
which was open to participation by all WHO member states, was to prepare
proposed draft elements of the FCTC and to submit a report to the Fifty-Third
World Health Assembly. The FCTC Working Group met in
Geneva, Switzerland in October 1999 and March 2000. The Working Group prepared
proposed draft elements of the convention and completed its work by submission
of a report to the 53rd World Health Assembly in May 2000. The World Health Assembly at its May
2000 meeting recognised the report of the FCTC Working Group containing
proposed texts as a sound basis for initiating formal negotiations on the FCTC.
Formal negotiations on the FCTC
commence with the convening of the first meeting of the Intergovernmental
Negotiating Body in Geneva from 16-21 October 2000. The Intergovernmental
Negotiating Body meeting is open to participation by all WHO member states. May 2000 to May 2003 has been
identified as the period for formal negotiations prior to the adoption of the
FCTC. FCTC
Outcomes WHO anticipates the FCTC will help
to: ·
Mobilise national and global technical and financial support for tobacco
control. ·
Raise awareness among several ministries likely to come into the loop of
global tobacco. ·
Raise awareness of various sectors of society directly concerned with
the public health aspects of tobacco. ·
Mobilise non-government organisations and other members of civil society
in support of tobacco control.(WHO FCTC technical briefing papers, 1999) [The foregoing is taken from the Australian Government website
on FCTC www.health.gov.au/fctc. WHO also has an extensive website on the
FCTC http://tobacco.who.int/en/fctc
which includes a FAQs compilation, press releases and background documents.] IMPLICATIONS
OF FCTC FOR THE ASIA/PACIFIC REGION
The benefits to be obtained
through implementation of the FCTC are obvious once the full extent of the
devastating impact of tobacco smoking is appreciated. However, the lessons of history teach
us that these objectives will not be achieved easily and will not be achieved
without considerable resistance from the tobacco industry. Already the tobacco industry has
developed a response to the WHO FCTC proposal, carefully crafted by public
relations consultants and tailored for particular regions around the world. For example, Philip Morris Asia
has released (through public relations advisor Burson/Marsteller) September 21
a "Call for reasonable tobacco regulation and cooperation with the World
Health Organization". A copy is shown below together with an appropriate
public response developed by the Hong Kong Council on Smoking and Health.
Response to tobacco industry attitude to FCTC The
statement from Philip Morris will not help to resolve the continuing problem of
promotion of tobacco to young people and their recruitment to nicotine
addiction. What is needed is tighter drafting of comprehensive legislation on
tobacco control, effective enforcement, and full compliance by the tobacco
industry. -
Philip Morris states that the company is committed to reach out to WHO and its
member states on the Framework Convention but Philip Morris has by its conduct
over the past 50 years forfeited any entitlement to be included in any such
process – they simply cannot be trusted.
The same goes for BAT. -
What Philip Morris calls “a cycle of hostility,
mistrust and recrimination” is in fact their reaction to an intellectually
honest approach, by the public health sector worldwide, to ensure that the
health of children and the public in general is defended. This process must not
be undermined by meaningless rhetoric from the industry. -
-
-
Of all the submissions to the WHO Public Hearings, the most
succint and potent, in my view, was one by ASH UK read out by Tania Amir, a
lawyer from Bangladesh. To do it
justice, I can do no more than set it out in full:
It
is clear that the harm caused by tobacco smoking can only be described as the
greatest deliberate infliction of harm on the human population of all time. The
sinister way in which this has occurred has now been exposed. The magnitude of
the problem requires an international response requiring a degree of
cooperation normally reserved for the case of widespread human conflict. As it
is, the death toll from tobacco is more than comparable with world wars of the
20th century. In World War II, for example, the total death toll,
civilian and military, has been estimated at 40 million or 8 million per year. WHO
calculations indicate that the death toll from tobacco is currently half that
rate and it will be exceeded by 2020. Moreover, the long latency period
involved with tobacco-related disease means that much of the damage has already
been done and as a consequence an annual global death toll between 4 and 10
million is likely to be experienced every year for the first two decades of the
21st century. The
importance of the FCTC cannot therefore be underestimated. Nor, given their
previous form, can the conduct of the tobacco industry. Hopefully
this paper will give some insight into the size of the problem, the source of
the problem and the possible solution to the problem. Fortunately there is now
a highly sophisticated infrastructure in existence to provide accurate and
reliable information as well as international support. This is probably best
done by the World Health Organisation Tobacco Free Initiative. Further
information can be obtained from the TFI website:
http://www.tobacco.who.int/en/fctc/ * LLB (Qld), LLM (Hons) (Syd). Wentworth Chambers 180
Philip St, SYDNEY 2000. [1] WHO estimates. See
TOBACCO ALERT, April 1996 The Tobacco Epidemic: A Global Public Health
Emergency http://www.who.int. [2] Wynder EL, Graham,
EA. Tobacco Smoking as a possible etiologic factor in bronchogenic carcinoma
Journal of the American Medical
Association, 1950; 143:329-36. [3] Levin ML,
Goldstein H, Gerhardt PR. Cancer and tobacco smoking Journal of the American Medical Association,
1950;143:336-8. [4] Doll R, Hill
AB. Smoking and carcinoma of the lung. Preliminary report British Medical Journal, 1950;ii:739-48. [5] Mills CA, Porter
MM. Tobacco smoking habits and cancer of the mouth and respiratory system
Cancer Res, 1950;10:539-42. [6] Schrek R,
Baker LA, Ballard GP, Dolgoff S. Tobacco smoking as an etiological factor in
disease Cancer Res, 1950;
10:49-58. [7] Peto R, Darby
S, Harz D, Silcocks P, Whitley E, Doll R, Smoking, smoking cessation, and
lung cancer in the UK since 1950: combination of national statistics with two
case-control studies British Medical
Journal, 2000; 321:323-329 (5 August). [8] Wynder, E.
Graham E, Crosinger A. Experimental Production of Carcinoma with Cigarette
Tar Cancer Res, 1953:13:855-864. [9] Pollay RW. A Scientific Smokescreen: A
Documentary History of Smoke Public Relations Efforts for and by the Tobacco
Industry Research Council (TIRC), 1954-1958 Vancouver, Canada: History of
Advertising Archives, 1990. Tobacco Industry Promotion Series. [10] Glantz SA and Ors,
Looking Through a Keyhole at the Tobacco Industry Journal of the American Medical Association, 1995; 274 No
3: 219-224 (19 July). [11] Kluger R, Ashes
to Ashes: America’s Hundred-Year Cigarette War, the Public Health, and the
Unabashed Triumph of Philip Morris Alfred
A. Knopf : New York, 1997. [12] Pringle P, Cornered:
Big Tobacco at the Bar of Justice Henry Holt and Co. : New York, 1998. [13] Mollenkamp C, Levy
A, Menn J and Rothfeder J, The People vs. Big Tobacco: How the States Took
On the Cigarette Giants Bloomberg Press : Princeton, 1998. [14] Zegart D, Civil
Warriors: The Legal Siege of the Tobacco Industry Delacorte Press : New
York, 2000. [15] Ryback DC and
Phelps D, Smoked: The Inside Story of the Minnesota Tobacco Trial MSP
Books : Minneapolis, 1998. [16] Philip Morris.
Cigarette Smoking. Health Issues for smokers, 13 Oct 1999. www.philipmorris.com/tobacco_bus/tobacco_issues/health_issues.html. [17] Fernandes E. FOCUS
– “No safe cigarette,” say UK Tobacco firms Reuters 2000: Jan 13. [18] Francey N and
Chapman S “Operation Berkshire”: The international tobacco companies’ conspiracy
British Medical Journal, 2000;
321:371-374. [19]
1964 US Surgeon General’s report. [20]
52nd US Surgeon General’s report. [21] Francey N, The war on tobacco – the global spread of
litigation against the tobacco companies Plaintiff, Feb 1999, 22-25. See also Daynard RA, Bates C and
Francey N, Tobacco Litigation Worldwide British Medical Journal, 2000; 320:111-113 (8 January). |